Drug Shortage Report for TEVA-TOBRAMYCIN
| Report ID | 227495 |
| Drug Identification Number | 02389622 |
| Brand name | TEVA-TOBRAMYCIN |
| Common or Proper name | TOBRAMYCIN 300mg/5ml |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | TOBRAMYCIN |
| Strength(s) | 60MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INHALATION INHALATION |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 56 |
| ATC code | J01GB |
| ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-05-08 |
| Estimated end date | 2025-06-10 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-04-24 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v26 | 2025-04-24 | French | Compare |
| v25 | 2025-04-24 | English | Compare |
| v24 | 2025-04-10 | French | Compare |
| v23 | 2025-04-10 | English | Compare |
| v22 | 2025-02-28 | French | Compare |
| v21 | 2025-02-28 | English | Compare |
| v20 | 2025-02-20 | French | Compare |
| v19 | 2025-02-20 | English | Compare |
| v18 | 2025-02-06 | French | Compare |
| v17 | 2025-02-06 | English | Compare |
| v16 | 2025-01-30 | French | Compare |
| v15 | 2025-01-30 | English | Compare |
| v14 | 2025-01-23 | French | Compare |
| v13 | 2025-01-23 | English | Compare |
| v12 | 2025-01-09 | French | Compare |
| v11 | 2025-01-09 | English | Compare |
| v10 | 2024-09-19 | French | Compare |
| v9 | 2024-09-19 | English | Compare |
| v8 | 2024-07-04 | French | Compare |
| v7 | 2024-07-04 | English | Compare |